Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial tight junctions are specialized multi-protein complexes located at the apical region of the lateral membranes between adjacent intestinal epithelial cells. They serve as a critical physical and functional barrier that regulates the paracellular passage of ions, solutes, water, and immune-active molecules from the intestinal lumen into underlying tissue. The main protein components include occludin, claudins (a family of proteins), and junctional adhesion molecules (JAMs). These proteins interact to form a selective seal that both demarcates cell polarity (“fence” function) and controls permeability (“gate” function). Tight junction integrity is dynamically regulated by various signaling pathways and can be disrupted in response to inflammatory cytokines such as interleukin 1β (IL‑1β), leading to increased intestinal permeability—a phenomenon implicated in multiple gastrointestinal diseases including inflammatory bowel disease. While not a single molecular target like an enzyme or receptor, modulation of tight junction structure or signaling is considered therapeutically relevant for restoring or enhancing barrier function in disease states[1][3][4]. “Intestinal epithelial tight junction/barrier function” refers to a structural complex and physiological property rather than a discrete molecular target such as an individual receptor or enzyme. It is not itself a canonical drug target but comprises several protein targets (e.g., occludin, claudins) that may be individually targeted for therapeutic purposes[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial tight junction.